I think the U.S mask sales and GP contraction is going to spook the market, further supporting the fear around GLP1s.
The investor call was dominated by questions about GLP1s and management released studies and internal findings that they are having no effect so far. Howver they believe there will be some impact.
The actual underlying result looks very strong to me. Probably get a chance to buy more shares over the coming days.
Ann: ResMed Announces Results for the First Quarter of FY2024, page-2
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$32.20 |
Change
-0.770(2.34%) |
Mkt cap ! $20.54B | |||
| Open | High | Low | Value | Volume |
| $32.20 | $32.30 | $31.88 | $50.58M | 1.576M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 31426 | $32.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $32.21 | 1525 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$32.13 |
Change
-0.770 ( 2.44 %) |
||||
| Open | High | Low | Volume | ||
| $32.22 | $32.31 | $31.90 | 539927 | ||
| Last updated 15.59pm 09/05/2024 ? | |||||
| RMD (ASX) Chart |